Document Detail


Analysis of risk factors for postmolar trophoblastic disease: categorization of risk factors and effect of prophylactic chemotherapy.
MedLine Citation:
PMID:  9048494     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Early identification of high risk molar pregnancy is important in preventing the development of subsequent postmolar trophoblastic disease (PMTD). In the present study, evaluation of risk factors of developing PMTD, and indications for initiating prophylactic chemotherapy, and investigation of the effects of prophylactic chemotherapy were undertaken. One hundred and forty complete molar pregnancies treated at Yonsei University College of Medicine were retrospectively analyzed. Thirty-six cases of PMTD developed in these molar pregnancies during follow-up. Risk factors for PMTD were ranked according to frequency with which they were associated with PMTD. The patients with no risk factors were classified in the low-risk group, with one or two in the medium-risk group, and with three or more in the high-risk group. Prophylactic chemotherapy was administered to 14 of 52 low-risk, to 21 of 46 medium-risk, and to 17 of 42 high-risk patients. Among the high-risk patients, the time required for remission was significantly shorter in the group with prophylactic chemotherapy (13.5 weeks) than in the group without prophylactic chemotherapy (22.4 weeks). There were no differences in the duration until remission among the low- and medium-risk patients. Of the 52 patients who received prophylactic chemotherapy, 8 (15.4%) developed PMTD. Among the high-risk patients the occurrence of PMTD was significantly lower in the prophylactic chemotherapy group. Among the low-risk and medium-risk patients, there were no differences in the occurrence of PMTD between the chemoprophylaxis treated and untreated groups. Our results strongly support the use of prophylactic chemotherapy for patients that were designed under our high risk criteria. Prophylactic chemotherapy helps to prevent or reduce the risk of developing PMTD, and shorten the time required for complete remission in high-risk patients.
Authors:
T K Park; S N Kim; S K Lee
Related Documents :
14506724 - Clinical significance of complex repetitive discharges: a case-control study.
12907344 - Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-contro...
22031204 - Body mass index in individuals with hiv infection and factors associated with thinness ...
2213074 - The use of risk factors in medical diagnosis: opportunities and cautions.
23703554 - Elevated red blood cell distribution width in healthy smokers.
15241834 - Reproductive factors and risk of breast carcinoma in a study of white and african-ameri...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Yonsei medical journal     Volume:  37     ISSN:  0513-5796     ISO Abbreviation:  Yonsei Med. J.     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-04-03     Completed Date:  1997-04-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0414003     Medline TA:  Yonsei Med J     Country:  KOREA    
Other Details:
Languages:  eng     Pagination:  412-9     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Therapy / adverse effects
Female
Humans
Hydatidiform Mole / complications*,  drug therapy*,  surgery
Incidence
Pregnancy
Remission Induction
Retrospective Studies
Risk Factors
Time Factors
Trophoblastic Tumor, Placental Site / epidemiology,  etiology,  prevention & control*
Uterine Neoplasms / prevention & control*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
Next Document:  Seroprevalence of rubella antibodies and effects of vaccination among healthy university women stude...